Stock data
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG) reported net income of -US$18.65M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$16.65M | -US$18.65M | — |
| 2024 | — | — | -US$13.74M | -US$11.16M | — |
| 2023 | — | — | -US$8.89M | -US$16.48M | — |
| 2022 | — | — | -US$4.47M | -US$5.12M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$4.12M | — |
| 2026-03-31 | — | -US$5.00M | — |
| 2025-12-31 | — | -US$3.24M | — |
| 2025-09-30 | — | -US$5.78M | — |
| 2025-06-30 | — | -US$4.66M | — |
| 2025-03-31 | — | -US$4.97M | — |
| 2024-12-31 | — | -US$3.10M | — |
| 2024-09-30 | — | -US$0.50M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.